Clinical Trial Update: Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial comparing cabazitaxel to vinflunine in metastatic or locally advanced urothelial carcinoma, with the study status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Jevtana (cabazitaxel)
• Vinflunine (vinflunine)

Snippet

Sponsor: Associació per a la Recerca Oncologica, Spain | Conditions: Urothelium Transitional Cell Carcinoma | Phase 2, Phase 3 | Status: UNKNOWN